Monsanto Invests in Pairwise after Cofounding CRISPR Startup

Pairwise Plants has raised a $25 million Series A round co-led by Monsanto Growth Ventures and healthcare investment firm Deerfield Management. Pairwise is a … More

CRISPR Startup Inscripta Raises $55.5m Series C to Democratize Gene-Editing

Inscripta (formerly Muse Bio) has raised a $55.5 million Series C round led by healthcare investor Mérieux Développement and Washington, DC-based private equity … More

Gene Editing Gets Public Market Approval as Calyxt Raises $64m IPO

Gene editing has caused a lot of excitement in agriculture technology circles for its potential to produce crops, and even … More